Upgrade to SI Premium - Free Trial

JPMorgan Upgrades Pacira Pharmaceuticals (PCRX) to Neutral

October 8, 2026 12:18 PM
JPMorgan analyst Hardik Parikh upgraded Pacira Pharmaceuticals (NASDAQ: PCRX) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Upgrades